Implications of amyloidosis on prostatic biopsy

Authors

  • NATHAN LAWRENTSCHUK,

    Corresponding author
    1. Department of Surgery, Division of Urology, Austin and Repatriation Medical Center, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • DAVID PAN,

    1. Department of Surgery, Division of Urology, Austin and Repatriation Medical Center, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • ROSS STILLWELL,

    1. Department of Surgery, Division of Urology, Austin and Repatriation Medical Center, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • DAMIEN M. BOLTON

    1. Department of Surgery, Division of Urology, Austin and Repatriation Medical Center, University of Melbourne, Melbourne, Australia
    Search for more papers by this author

Nathan Lawrentschuk md, 10 Mary Street, Beaumaris, Victoria 3193, Australia. Email: nayjay@ozemail.com.au

Abstract

Abstract  Transrectal ultrasound-guided biopsy of the prostate is an integral step in the investigation of patients at risk of prostate adenocarcinoma. With an increasing number of biopsies being performed, uncommon forms of prostatic pathology will be identified more frequently. Amyloidosis of the prostate and/or the seminal vesicles may be noted on transrectal ultrasound-guided biopsy of the prostate and the implications of this histological diagnosis must be understood. We present our experience of two such cases of amyloidosis and review the literature regarding their management.

Ancillary